RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $19,000 | -80.2% | 3,374 | -66.0% | 0.00% | – |
| Q4 2021 | $96,000 | -49.2% | 9,935 | -6.2% | 0.00% | -100.0% |
| Q3 2021 | $189,000 | -26.5% | 10,593 | +0.5% | 0.00% | 0.0% |
| Q2 2021 | $257,000 | +38.9% | 10,537 | +50.9% | 0.00% | 0.0% |
| Q1 2021 | $185,000 | – | 6,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,506,526 | $6,546,109 | 0.21% |
| HARBOURVEST PARTNERS LLC | 986,878 | $172,704 | 0.06% |
| Artal Group S.A. | 2,042,666 | $357 | 0.02% |
| Virtu Financial LLC | 68,825 | $12 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,277,196 | $222 | 0.00% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 640,000 | $110,144 | 0.00% |
| Baillie Gifford | 4,869,126 | $837,977 | 0.00% |
| Citadel Advisors | 600 | $103 | 0.00% |
| Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 2,196 | $0 | 0.00% |